login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
PROFOUND MEDICAL CORP (PROF) Stock News
NASDAQ:PROF -
CA74319B5027
-
Common Stock
4.47
USD
-0.06 (-1.32%)
Last: 8/29/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
PROF Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
4 days ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
16 days ago - By: Zacks Investment Research
- Mentions:
ZVRA
Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates (Revised)
17 days ago - By: The Motley Fool
Profound Medical Posts Wider Loss in Q2
4 months ago - By: Benzinga
- Mentions:
MSC
ELUT
ACIW
JYNT
...
Earnings Scheduled For May 8, 2025
17 days ago - By: Zacks Investment Research
- Mentions:
MODV
Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates
17 days ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical Announces Second Quarter 2025 Financial Results
17 days ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical Announces Second Quarter 2025 Financial Results
19 days ago - By: Zacks Investment Research
- Mentions:
ZVRA
Zevra Therapeutics (ZVRA) Reports Q2 Loss, Tops Revenue Estimates
24 days ago - By: Zacks Investment Research
- Mentions:
RLAY
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue Estimates
18 days ago - By: Benzinga
- Mentions:
BTCM
DE
TIC
DFLI
...
Earnings Scheduled For August 14, 2025
a month ago - By: Zacks Investment Research
- Mentions:
MDGL
Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates
a month ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
a month ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
3 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
3 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
3 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
3 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
4 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
4 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
4 months ago - By: Zacks Investment Research
- Mentions:
ENTA
Profound Medical (PROF) Reports Q1 Loss, Misses Revenue Estimates
4 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical Announces First Quarter 2025 Financial Results
4 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
4 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
4 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
4 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
4 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
4 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
4 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
4 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
5 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
5 months ago - By: Profound Medical Corp.
- Mentions:
PRN.CA
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
Please enable JavaScript to continue using this application.